Skip to main content
. 2021 Sep 20;10(9):1130. doi: 10.3390/antibiotics10091130

Figure 4.

Figure 4

The voriconazole trough concentrations by days of 8 patients who had targeted C0 but supratherapeutic C1 during the constant unchanged therapy dosage of voriconazole (n = 38).